Eggesbø H B, Søvik S, Dølvik S, Eiklid K, Kolmannskog F
Department of Radiology, Aker University Hospital, 0514, Oslo, Norway.
Eur Radiol. 2003 Jun;13(6):1451-60. doi: 10.1007/s00330-003-1825-8. Epub 2003 Apr 5.
The purpose of this study was to develop a paranasal sinus CT scoring system that could be used as a diagnostic tool to discriminate cystic fibrosis (CF) patients from control patients examined for sinonasal disease. The model should include as few and easily applicable criteria as possible, supported by statistical analyses and clinical judgement. We used data from 116 CF and 136 control patients. The CF patients were grouped according to the number of confirmed CF mutations: genetically verified (CF-2), or based on sweat testing and clinical findings alone (CF-1, CF-0). Nine paranasal sinus CT criteria, including development, pneumatisation variants and inflammatory patterns, were evaluated. The final model included three criteria: (a) frontal and (b) sphenoid sinus development, and (c) absence of three pneumatisation variants. This model discriminated CF-2 from controls with overlap of summed scores in only 8 of 206 patients. When this model was applied in the CF-1 and CF-0 groups, two populations seemed to exist. A larger group with summed scores overlapping that of the CF-2 group and a smaller group with summed scores overlapping that of the control group. We conclude that this CT scoring system may support, as well as exclude, a CF diagnosis in cases of diagnostic uncertainty.
本研究的目的是开发一种鼻窦CT评分系统,该系统可作为一种诊断工具,用于区分囊性纤维化(CF)患者和因鼻窦疾病接受检查的对照患者。该模型应包含尽可能少且易于应用的标准,并得到统计分析和临床判断的支持。我们使用了116例CF患者和136例对照患者的数据。CF患者根据确诊的CF突变数量进行分组:基因验证组(CF-2),或仅基于汗液检测和临床发现的组(CF-1,CF-0)。对包括发育、气化变异和炎症模式在内的9项鼻窦CT标准进行了评估。最终模型包括三项标准:(a)额窦和(b)蝶窦发育,以及(c)不存在三种气化变异。该模型区分CF-2与对照,在206例患者中只有8例总分重叠。当将该模型应用于CF-1和CF-0组时,似乎存在两个人群。一个较大的组总分与CF-2组重叠,一个较小的组总分与对照组重叠。我们得出结论,在诊断不确定的情况下,这种CT评分系统可能有助于支持或排除CF诊断。